mannitol has been researched along with Influenza, Human in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bannister, R; Fernandez, A; Frijlink, HW; Hak, E; Huckriede, A; Liu, H; Norley, S; Oftung, F; Pleguezuelos, O; Stoloff, G; van Doorn, E | 1 |
| Michie, HR; O'Dwyer, ST; Revhaug, A; Smith, RJ; Wilmore, DW; Ziegler, TR | 1 |
1 trial(s) available for mannitol and Influenza, Human
| Article | Year |
|---|---|
Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.
Topics: Adolescent; Adult; Antibodies, Viral; Double-Blind Method; Enzyme-Linked Immunospot Assay; Epitopes; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunogenicity, Vaccine; Influenza Vaccines; Influenza, Human; Male; Mannitol; Middle Aged; Oleic Acids; Orthomyxoviridae; Vaccines, Synthetic; Young Adult | 2017 |
1 other study(ies) available for mannitol and Influenza, Human
| Article | Year |
|---|---|
A single dose of endotoxin increases intestinal permeability in healthy humans.
Topics: Administration, Oral; Adult; Endotoxins; Escherichia coli; Humans; Influenza, Human; Injections, Intravenous; Intestinal Absorption; Lactulose; Leukocyte Count; Lipopolysaccharides; Male; Mannitol; Norepinephrine; Stimulation, Chemical; Time Factors | 1988 |